1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow rVA576: new trials by email Literature Review of rVA576 trials Research Report on rVA576
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576 rVA576, Standard of care (SOC) - Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 3 | Completed | AKARI Therapeutics | 9 | 2018-06-07 | 2025-04-09 |
| rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study rVA576 - Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | Terminated | AKARI Therapeutics | 15 | 2017-03-13 | 2025-04-10 |
Hemoglobinuria, Paroxysmal (2)
Kazakhstan (1) · Lithuania (1) · Poland (1) · Sri Lanka (1)
Andrius Degulys, MBBS (1) · Wynne Weston Davies (1)